The Chiesi Group is today one of the main pharmaceutical industries in Europe, with an extensive line of products in diverse therapeutic segments. Headquartered in Parma, Italy, the group operates in all continents, with 22 direct affiliates, 3 production plants (Italy, France and Brazil) and 4 research and development centers for new products and technologies (Italy, France, the United States and the UK).
Brazilian affiliate Chiesi Farmacêutica Ltda. has been operating in the country for 40 years, and offers medicines characterized by high quality and reliability recognized as such all over the world. Our area of activity includes several specialist fields such as: Neonatology, Respiratory Tract Diseases (asthma and chronic obstructive pulmonary disease), allergic diseases (rhinitis), cardiovascular diseases (hypertension), and musculoskeletal and supplements with polyamine acids. In addition, we work with technologies that make life easier for patients, such as inhalers and spacers for the administration of inhaled drugs.
Our facilities in Brazil comprise a factory certified by Anvisa [the Brazilian National Health Surveillance Agency] and by European regulatory agencies, located in the municipality of Santana de Parnaíba [state of São Paulo], and the central office in the city of São Paulo [state of São Paulo].
Our commitment is to generate value today and in the future through entrepreneurship and innovation. In this context, the Department of New Business Development and New Products acts as a strategic lever to expand the platforms of action, seeking to strengthen the areas in which we already operate and to enter new and promising markets.
We are interested in establishing partnerships with national and multinational companies for various types of projects, such as acquisitions, mergers, joint ventures, distribution agreements, licensing, co-marketing, co-promotion, co-development and technology transfer, aimed at a sustainable commitment over time.
The Chiesi Group has more than 3,800 employees worldwide, with more than 350 in Brazil. One-third of this local team is dedicated exclusively to scientific dissemination for more than 20 thousand Brazilian physicians.
Ethics and transparency are important values for us. Being an ethical, respectable and trustworthy partner is our commitment.
To send us a project or learn more about our partnership policy, use the form below:
